021-51111890
购物车（）
sales@molnova.cn
EMD-281014 hydrochloride
CAS No. 443144-27-2
EMD-281014 hydrochloride ( Pruvanserin;LSN2411347;LY-2422347 )
产品货号. M14513 CAS No. 443144-27-2
EMD-281014 hydrochloride ((Pruvanserin, LSN2411347, LY-2422347)) is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥7857 | 有现货 |
|
| 50MG | ￥16038 | 有现货 |
|
| 100MG | ￥20250 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称EMD-281014 hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述EMD-281014 hydrochloride ((Pruvanserin, LSN2411347, LY-2422347)) is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM.
-
产品描述EMD-281014 hydrochloride ((Pruvanserin, LSN2411347, LY-2422347)) is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM, displays little to no affinity for 5-HT2C receptors (Ki=557 nM), human D2 receptors and IKr channels; significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test; reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset.Sleep Disorder Discontinued
-
同义词Pruvanserin;LSN2411347;LY-2422347
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT Receptor
-
研究领域Neurological Disease
-
适应症Sleep Disorder
化学信息
-
CAS Number443144-27-2
-
分子量412.89
-
分子式C22H22ClFN4O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC1CN(CCN1CCC2=CC=C(C=C2)F)C(=O)C3=CC=CC4=C3NC=C4C#N.Cl
-
化学全称7-[[4-[2-(4-Fluorophenyl)ethyl]-1-piperazinyl]carbonyl]-1H-indole-3-carbonitrile hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hamadjida A, et al. Neuropharmacology. 2018 Jun 30;139:61-67.
2. Lauffer L, et al. J Pharmacol Exp Ther. 2016 Jul;358(1):39-49.
3. Patel JG, et al. Synapse. 2004 Apr;52(1):73-5.
4. Ladduwahetty T, et al. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3201-4.
2. Lauffer L, et al. J Pharmacol Exp Ther. 2016 Jul;358(1):39-49.
3. Patel JG, et al. Synapse. 2004 Apr;52(1):73-5.
4. Ladduwahetty T, et al. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3201-4.
产品手册
关联产品
-
2-Bromo-6-methoxynap...
Inhibitors of serotonin reuptake.
-
Landipirdine
A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.
-
GR 46611
GR 46611 is a selective 5-HT1B and 5-HT1D receptor agonist and can be used in studies about the treatment of epilepsy.
